Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Awatar Maurya

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The Journal of Organic Chemistry|April 8, 2015
One-pot, three-component approach to the synthesis of 3,4,5-trisubstituted pyrazolesAhmed Kamal, K N Visweswara Sastry, D Chandrasekhar, et al.
Organic & Biomolecular Chemistry|October 8, 2016
Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocinesK N Visweswara Sastry, Sunitha Rani Routhu, Soma Gupta Datta, et al.
Archiv Der Pharmazie|September 13, 2024
New hydrazide derivatives of N-amino-11-azaartemisinin as promising epidermal growth factor receptor inhibitors for therapeutic development in triple-negative breast cancerManvika Karnatak, Priyanka Yadav, Komal Rathi, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The Journal of Organic Chemistry|April 8, 2015
One-pot, three-component approach to the synthesis of 3,4,5-trisubstituted pyrazolesAhmed Kamal, K N Visweswara Sastry, D Chandrasekhar, et al.
Organic & Biomolecular Chemistry|October 8, 2016
Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocinesK N Visweswara Sastry, Sunitha Rani Routhu, Soma Gupta Datta, et al.
Archiv Der Pharmazie|September 13, 2024
New hydrazide derivatives of N-amino-11-azaartemisinin as promising epidermal growth factor receptor inhibitors for therapeutic development in triple-negative breast cancerManvika Karnatak, Priyanka Yadav, Komal Rathi, et al.
Pageof 4